178 related articles for article (PubMed ID: 35220304)
1. Pentraxin 3 Predicts Arteriovenous Fistula Functional Patency Loss and Mortality in Chronic Hemodialysis Patients.
Tsai HC; Ou SM; Wu CC; Huang CC; Hsieh JT; Tseng PY; Lee CY; Yang CY; Tarng DC
Am J Nephrol; 2022; 53(2-3):148-156. PubMed ID: 35220304
[TBL] [Abstract][Full Text] [Related]
2. C-reactive protein as a prognostic risk factor for loss of arteriovenous fistula patency in hemodialyzed patients.
Stirbu O; Gadalean F; Pitea IV; Ciobanu G; Schiller A; Grosu I; Nes A; Bratescu R; Olariu N; Timar B; Tandrau MC
J Vasc Surg; 2019 Jul; 70(1):208-215. PubMed ID: 30792061
[TBL] [Abstract][Full Text] [Related]
3. Chitinase-3-like protein 1 is an independent risk factor for the early failure of forearm autologous arteriovenous fistulas in uremic patients.
Liang L; Chen Q; Cao W; Tang L; Wei Y; Ding N; Kong X; Xu D
Ther Apher Dial; 2021 Dec; 25(6):939-946. PubMed ID: 33486888
[TBL] [Abstract][Full Text] [Related]
4. Fibroblast growth factor 21 predicts arteriovenous fistula functional patency loss and mortality in patients undergoing maintenance hemodialysis.
Hu X; Ding H; Wei Q; Chen R; Zhao W; Jiang L; Wang J; Liu H; Cao J; Liu H; Wang B
Ren Fail; 2024 Dec; 46(1):2302407. PubMed ID: 38197433
[TBL] [Abstract][Full Text] [Related]
5. Arteriovenous Fistula Placement, Maturation, and Patency Loss in Older Patients Initiating Hemodialysis.
Qian JZ; McAdams-DeMarco M; Ng DK; Lau B
Am J Kidney Dis; 2020 Oct; 76(4):480-489.e1. PubMed ID: 32654891
[TBL] [Abstract][Full Text] [Related]
6. Arteriovenous fistula formation with adjuvant endovascular maturation.
Thomas SD; Sideris A; Narroway H; McLachlan R; Robertson C; Crowe P; Varcoe RL
J Vasc Surg; 2022 Feb; 75(2):641-650.e2. PubMed ID: 34506894
[TBL] [Abstract][Full Text] [Related]
7. Thrombophilia and arteriovenous fistula survival in ESRD.
Salmela B; Hartman J; Peltonen S; Albäck A; Lassila R
Clin J Am Soc Nephrol; 2013 Jun; 8(6):962-8. PubMed ID: 23411429
[TBL] [Abstract][Full Text] [Related]
8. International Comparisons of Native Arteriovenous Fistula Patency and Time to Becoming Catheter-Free: Findings From the Dialysis Outcomes and Practice Patterns Study (DOPPS).
Pisoni RL; Zepel L; Zhao J; Burke S; Lok CE; Woodside KJ; Wasse H; Kawanishi H; Schaubel DE; Zee J; Robinson BM
Am J Kidney Dis; 2021 Feb; 77(2):245-254. PubMed ID: 32971192
[TBL] [Abstract][Full Text] [Related]
9. Medicare Costs Associated With Arteriovenous Fistulas Among US Hemodialysis Patients.
Thamer M; Lee TC; Wasse H; Glickman MH; Qian J; Gottlieb D; Toner S; Pflederer TA
Am J Kidney Dis; 2018 Jul; 72(1):10-18. PubMed ID: 29602630
[TBL] [Abstract][Full Text] [Related]
10. Mid-term cumulative patency of fistula and PTFE grafts among hemodialysis patients: A retrospective, single-center study from Palestine.
Khanfar O; Aydi R; Saada S; Shehada M; Hamdan Z; Sawalmeh O; Hassan M; Hammoudi A; Nazzal Z
J Vasc Access; 2023 Jul; 24(4):559-567. PubMed ID: 34431381
[TBL] [Abstract][Full Text] [Related]
11. Contemporary outcomes of a "snuffbox first" hemodialysis access approach in the United States.
Heindel P; Dieffenbach BV; Sharma G; Belkin M; Ozaki CK; Hentschel DM
J Vasc Surg; 2021 Sep; 74(3):947-956. PubMed ID: 33667611
[TBL] [Abstract][Full Text] [Related]
12. Pentraxin 3 and complement cascade activation in the failure of arteriovenous fistula.
Castellano G; Di Vittorio A; Dalfino G; Loverre A; Marrone D; Simone S; Schena FP; Pertosa G; Grandaliano G
Atherosclerosis; 2010 Mar; 209(1):241-7. PubMed ID: 19772962
[TBL] [Abstract][Full Text] [Related]
13. Patients started on hemodialysis with tunneled dialysis catheter have similar survival after arteriovenous fistula and arteriovenous graft creation.
Yuo TH; Chaer RA; Dillavou ED; Leers SA; Makaroun MS
J Vasc Surg; 2015 Dec; 62(6):1590-7.e2. PubMed ID: 26372193
[TBL] [Abstract][Full Text] [Related]
14. Effects of plasma atherogenic index and plasma osmolality on arteriovenous fistula patency in hemodialysis patients.
Güven C; Pala AA; Urcun YS
J Vasc Access; 2023 Jan; 24(1):64-70. PubMed ID: 34112020
[TBL] [Abstract][Full Text] [Related]
15. Assessment of Use of Arteriovenous Graft vs Arteriovenous Fistula for First-time Permanent Hemodialysis Access.
Hicks CW; Wang P; Kernodle A; Lum YW; Black JH; Makary MA
JAMA Surg; 2019 Sep; 154(9):844-851. PubMed ID: 31188411
[TBL] [Abstract][Full Text] [Related]
16. Vascular access for hemodialysis in the elderly.
Arhuidese IJ; Cooper MA; Rizwan M; Nejim B; Malas MB
J Vasc Surg; 2019 Feb; 69(2):517-525.e1. PubMed ID: 30683199
[TBL] [Abstract][Full Text] [Related]
17. Comparison of Ellipsys Percutaneous and Proximal Forearm Gracz-Type Surgical Arteriovenous Fistulas.
Shahverdyan R; Beathard G; Mushtaq N; Litchfield TF; Vartanian S; Konner K; Jennings WC
Am J Kidney Dis; 2021 Oct; 78(4):520-529.e1. PubMed ID: 33662481
[TBL] [Abstract][Full Text] [Related]
18. Patients with lower extremity dialysis access have poor primary patency and survival.
Pike SL; Farber A; Arinze N; Levin S; Cheng TW; Jones DW; Tan TW; Malas M; Rybin D; Siracuse JJ
J Vasc Surg; 2019 Dec; 70(6):1913-1918. PubMed ID: 31147128
[TBL] [Abstract][Full Text] [Related]
19. Outcomes of arteriovenous fistula creation after the Fistula First Initiative.
Schinstock CA; Albright RC; Williams AW; Dillon JJ; Bergstralh EJ; Jenson BM; McCarthy JT; Nath KA
Clin J Am Soc Nephrol; 2011 Aug; 6(8):1996-2002. PubMed ID: 21737851
[TBL] [Abstract][Full Text] [Related]
20. Effects of cardiovascular medications on primary patency of hemodialysis arteriovenous fistula.
Chang TI; Chen CH; Hsieh HL; Chen CY; Hsu SC; Cheng HS; Huang WC; Sue YM; Hsu YH; Lin FY; Shih CM; Lin SJ; Huang PH; Liu CT
Sci Rep; 2020 Jul; 10(1):12135. PubMed ID: 32699337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
